Long-term Effects of Methadone for Cancer Pain

Status Recruiting

Clinical Trial Summary

The methadone is an useful opioid for the cancer pain treatment, mostly used in second or last line during the opioid rotation. The Methadone had an anti-MNDA effect, and clinicians agree that the methadone could have an effect in neuropathic cancer pain. During a previous study the investigators find that the pain was still improving after the week 2, but they had only a small number of patients still included at this stage and they cannot conclude.

The investigators decide to follow up systematically all the patients undergoing a methadone treatment for cancer pain, at day 28, to study the hypothesis about the long-term pain improvement.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Cancer Pain

Clinical Trial Details

NCT number	NCT02856399
Study type	Observational
Source	Hospices Civils de Lyon
Contact	Marilene FILBET, Pr Associate
Phone	(0)478864148
Email	marilene.filbet@chu-lyon.fr
Status	Recruiting
Phase	N/A
Start date	November 2014
Completion date	August 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03375515` - PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain	Phase 3
Recruiting	`NCT03431922` - Endovascular Denervation in Patients With Cancer Pain	N/A
Not yet recruiting	`NCT05265052` - 3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain	Phase 2
Withdrawn	`NCT05325164` - Methadone for 'Adenocarcinopathic' Pain Treatment	Phase 3
Completed	`NCT02664987` - Analgesic Treatment for Cancer Pain in South East Asia	N/A
Completed	`NCT01946555` - Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain	N/A
Active, not recruiting	`NCT04095234` - Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)	Phase 2
Recruiting	`NCT05800834` - Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds	Phase 2
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Completed	`NCT02609828` - Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy	Phase 3
Completed	`NCT03331055` - PENS or TENS for Pain in Pancreatic Cancer	N/A
Recruiting	`NCT05506878` - Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement	N/A
Completed	`NCT00766831` - An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain	Phase 4
Recruiting	`NCT05051735` - PARASTOP - Paracetamol With Strong Opioids	Phase 3
Not yet recruiting	`NCT05348174` - Randomized Controlled Trial of Virtual Reality Assisted Guided Imagery (VRAGI) for Pain in Advanced Cancer Patients.	N/A
Completed	`NCT05209906` - An Observation Study to Assess the Efficacy and Safety of Proportional Doses of Painkyl® in Patients With Breakthrough Cancer Pain
Completed	`NCT03031938` - Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies	Phase 3
Not yet recruiting	`NCT05594459` - Early Treatment With Invasive Technique in Cancer Pain Management	N/A
Withdrawn	`NCT04666623` - Compare the Efficacy and Safety of Intranasal Esketamine in Chronic Opioid Refractory Pain	Phase 2
Not yet recruiting	`NCT05049811` - Effects of Mobile Medicine on Cancer Patients	N/A